PARTNERS

Maggioli is one of the biggest ICT integrators in Italy, a leader in the provision of complete IT solutions and services to the Local Public sector: more than 6,000 Municipalities out of 8,048 in Italy run Maggioli’s technology in addition to more than 3,800 museums and 1500 SMEs. MAG’s expertise covers the analysis, design and development of information systems in various technological environments for large and small customers. The company holds significant know-how in the e-Health domain, having developed numerous ICT products and solutions for the management of social and health services.   

Maggioli Greece, the team coordinating the INCISIVE project, is acting as a near-shore extension of Maggioli Research and Innovation Unit and it is fully integrated with it. To this respect, the researchers of Maggioli Greece are participating in the implementation of most of Maggioli Group’s research and innovation international projects. 

Partner’s role:

Gruppo Maggioli, notably Maggioli Greece, is the INCISIVE Project Coordinator and leads Quality Assurance. MAG also acts as INCISIVE Integration Manager, providing the technological infrastructure required for the integration of INCISIVE’s AI services and being responsible for the three iterations of the INCISIVE prototypes. In addition, the company contributes to several other project tasks, including the definition of technological requirements and the development of AI tools, dissemination and exploitation activities. 

The Institute of Communication and Computer Systems (ICCS) of the School of Electrical and Computer Engineering (ECE) of the National Technical University of Athens (NTUA) was founded in 1992. It was founded with the ‘charta’ to support the performance of top-quality research, development activities and the provision of scientific service to private and public bodies. Essentially the mission of ICCS was to support the deployment, the realization and the growth of the research priorities of ECE mainly through seeking, pursuing and acquiring research funding via the competitive calls for research proposals that the European Commission had instigated. In turn its purpose has been to build a research personnel base alongside ECE’s faculty so as to conduct state-of-the-art research and at the same time improve the research laboratory equipment base and infrastructures of the School.

Partner’s role:

ICCS contributes to INCISIVE by leading the AI and user interaction work package. ICCS will incorporate advanced machine learning and data fusion techniques able to detect cancerous regions in medical images.

The Centre of Research and Technology (CERTH) is a non-profit organisation, it is one of the leading research centres in Greece and it is listed among the TOP-20 E.U. research institutions. It has important scientific and technological achievements in many areas, the most prudent of which: Energy, Environment, Industry, Mechatronics, Information & Communication, Transportation & Sustainable Mobility, Health, Agro-biotechnology, Smart farming, Safety & Security. CERTH employs more than 700 people, mostly scientific associates. It hosts, among other four institutes, the Information Technologies Institute (ITI). 

The Information Technologies Institute (ITI) was founded in 1998, being a founding member of CERTH and it is based in Thessaloniki. ITI has participated in more that 400 research projects and employs more than 200 scientific personnel. It is further internally divided the following research units: Virtual & Augmented Reality Lab, Visual Analytics Lab, Visual Computing Lab, Cognitive Systems & Robotics Laboratory, Multimedia, Knowledge and Social Media Analytics Lab, Communication & Networking Lab, e-Services, e-Learning and e-Government Lab, Additive Manufacturing Research Unit and the Smart Home Research Infrastructure. 

Partner’s role: 

CERTH will greatly contribute to technical aspects concerning data manipulation techniques and development of new AI tools. Through many years of experience on the required subjects it will lead Task 4.4: “Transforming medical images to medical reports and recommendation mechanism”, Task 4.7:” AR enhanced visualization and re-training framework”. It will also coordinate actions related with the secure and GDPR-compliant data storage and data sharing using blockchain technologies, through Task 5.2:” Automated data curation, annotation and anonymization mechanisms” and Task 5.5:” Secure sharing of data and images”. CERTH will be further involved in the system integration actions, as well as to the horizontal actions and will contribute to all Work Packages. 

CeRICT (Centro Regionale Information Communication Technology) is a research consortium founded in 2005 as a no-profit organization to foster the cooperation of Italian computer scientists and engineers in nation-wide and international projects in the area of Information and Communication Technology (ICT). It currently comprises eight partners, and precisely: universities (among which the University of Naples Parthenope), the Consorzio Interuniversitario Nazionale per l’Informatica (CINI), Consiglio Nazionale delle Ricerche (CNR), and the Pascale Foundation.

Partner’s role:

CeRICT will be responsible for the development of INCISIVE identity management mechanisms and will contribute to the implementation of security and privacy features of the project infrastructure.

BSC is at the service of the international scientific community and of an industry that requires HPC resources. Our multidisciplinary research team and our computational facilities –including MareNostrum– make BSC an international centre of excellence in e-Science. Since its establishment in 2005, BSC has developed an active role in fostering HPC in Spain and Europe as an essential tool for international competitiveness in science and engineering. The centre manages the Red Española de Supercomputación (RES) and is a hosting member of the Partnership for Advanced Computing in Europe (PRACE) initiative. We actively participate in the main European HPC initiatives, in close cooperation with other European supercomputing centres.

The BSC-CNS Computer Sciences Department focuses on building upon currently available hardware and software technologies and adapting these technologies to make efficient use of supercomputing infrastructures. The department proposes a novel architecture for processors and memory hierarchy and develops programming models and innovative implementation approaches for these models as well as tools for performance analysis and prediction.

Partner’s role:
The Barcelona Supercomputing Center contributes to the INCISIVE Project as a research partner, leading tasks on High-Performance Computing optimization also introducing HPC environments for the AI-related applications in the project. Additionally, we are in charge of proposing a Federated Learning architecture for the INCISIVE AI applications.

European Dynamics is a leading European software vendor and information & ICT services provider, operating internationally. European Dynamics designs, develops, supports and promotes software ICT applications using open architectures and integrated, state-of-art technology to governments, public organizations and private enterprises in more than 45 countries.

Partner’s role:

ED will actively contribute to the development of the INCISIVE pan- European federated repository to enable donation and sharing of cancer data in compliance with ethical, legal and privacy demands for, among others, Artificial Intelligence based solutions experimentations.

Telesto IoT Solutions (TIS) is an innovation-driven SME active in IoT applications, was established in 2017. The company provides state-of-the-art solutions in the area of Internet-of-Things (IoT), sensor networks and ways for retrieval, dynamic composition and use of sensor-generated data. Fields of applications include sustainable urban environment & city resource management, digital city services, emergency response, customer loyalty and analytics, fixed and mobile assets management e.t.c.

The company builds on the experience acquired through the founding team’s participation in national and EU-funded projects and aims to establish soon a self-sustainable presence in the UK and European markets, building largely on innovative concepts in the area of safety and security.

Partner’s role:

TIS is responsible for INCISIVE’s Technical Manager and will coordination of the scientific/technical work, including technical progress monitoring, assessment of the exchange of technical information among partners, supervision of technical deliverables. Additionally, it will actively contribute to the project’s technical activities focusing on integration activities.

Lead User requirements definition and system design, developing scenarios of use to drive the complete design and outline technical requirements, and coordinating the definition of the overall INCISIVE architecture and the main components.

Squaredev is a Belgium-based SME focusing on AI-driven big data analytics. SQD applies AI research in numerous fields through the combination of data science and computer science. Cancer diagnosis and classification, pandemics and linked open data are some of the fields that SQD deals with in order to apply the findings. Using neural networks, natural language processing and graphs at scale, SQD solves problems that the human brain is incapable of. The core value of the systems is that they are accessible and understandable by everyone (explainable AI). The advances are always directed at improving the quality of life.

Partner’s role:

Squaredev is one of the technical and research partners of INCISIVE Project. SQD will be involved in the development of the INCISIVE automated annotation mechanism, as well as it will be involved in the implementation of data analytics and ML features.

AUTH is the largest university in Greece covering all disciplines. (https://www.auth.gr/en). It is widely recognized as a vibrant centre of learning. The School of Medicine is one of the most important and well-established Schools in Greece, both quantitatively and qualitatively, comprising the biggest School in the country regarding its enrolment, and its members are the stuff of several hospitals as well as other units of the National Health System, and thus provides an important social work.

The Lab of Computing, Medical Informatics and Biomedical Imaging Technologies at the School of Medicine, AUTH, founded in 1990. Within the Lab, the BiOasys team, led by Prof I Chouvarda, works on the development of biomedical data analytic methods & integrated data-driven approaches, the exploration of AI for health-related predictive models, the incorporation of AI in connected health technologies & systems medicine, and the link between systems medicine, daily life health data & connected health technologies.

The AHEPA University Hospital is one of the largest Hospitals in North Greece with more than 680 beds and covers all the spectrum of medical and surgical specialities of medicine as well as the psychiatric sector. The Radiology Department of AHEPA offers all the spectrum of Diagnostic and Interventional procedures to a population of 1.5 million inhabitants.

The Dept of Autopsy Histopathology of the Lab. Forensic Medicine and Toxicology at AUTH were founded in 2015. It is recognised for the provision of specialized histopathological diagnoses in forensic specimens. its research interests involve respiratory-lung cancer, myocardial diseases (for example infarction, cardiomyopathies, cancer), brain diseases (for example dementia, Alzheimer, brain tumours), perinatal pathology, molecular pathology, biobanking and general oncology.

Partner’s role: 

The role of AUTH in INCISIVE is based on two pillars. On one hand, AUTH serves as a data provider for different cancers, while on the other hand, AUTH serves as a technical partner. In this respect, the AUTH team coordinates the data management, the integration of the existing data sources as well as the data collection. In addition, the implementation of diverse types of pipelines, such as the descriptive, the predictive and prescriptive ones, comprise the main contributions of AUTH team in the INCISIVE project. This work will be based on the development of data analytics and machine learning methods, while a significant effort will be paid to the interpretability of the extracted knowledge and the output of the predictive models. Furthermore, the validation of the whole INCISIVE system before the start of the pilot studies will be undertaken by AUTH team. Finally, AUTH will be also involved in several other project tasks including the definition of technological requirements, the design, and the ethical approval actions.

UNS is one of the largest educational and research centres in Central Europe, with more than 50,000 students and 5,000 teaching and non-teaching staff. It offers 350 study programmes at all academic levels continuously improved to stay up-to-date with the latest research. It is a comprehensive university covering all major fields of study and research within its member units, 14 faculties and 3 research institutes. The project will be carried out by the Faculty of Technical Sciences (UNS-FTS) and Faculty of Medicine (UNS-FM).

UNS-FTS comprises 11 departments and it is the largest individual faculty in Serbia with over 10,000 students. The participating research group from the Department of Power Electronics and Communication Engineering is specialized in signal processing, machine learning and information and communication technologies (ICONIC centre). It has established links towards local and regional healthcare and medical research institutions with ongoing collaboration with several biomedical and bioinformatics research groups in EU.

UNS-FM is an autonomous centre of excellence for health education and scientific progress with more than 500 professors, that offers 14 study programs in Serbian and English. The teaching base of the Faculty of Medicine Novi Sad includes the departments and institutes of the Clinical centre of Vojvodina, Institute of Cardiology, Lung Diseases and Oncology in Sremska Kamenica, Institute for Health Protection of Children and Youth, Pharmaceutical Institution of Vojvodina. The project will be carried out by researchers from Medical faculty, engaged as clinicians with Oncology Institute of Vojvodina.

Partner’s role:

UNS-FTS is involved as a technical partner to contribute to data collection-related challenges, image preprocessing, DNN modelling and multimodal analytics pipelines. UNS-FM is involved as a data provider and pilot site for breast and colorectal cancer. UNS will help in defining the INCISIVE user requirements and identifying challenges in efficient diagnostics and follow-up experienced in clinical practice.

Visaris is a privately-owned SME company active in the field of diagnostic imaging. Visaris develops, manufactures and implements a range of digital x-ray systems from x-ray imaging acquisition and control stations to complete diagnostic x-ray systems as well as fully integrated film-less and paper-less diagnostic workflow solutions for radiology departments and diagnostic imaging centres including diagnostic radiology workstations including advanced automated image analysis tools, image archives and radiology information systems. Visaris maintains an integrated quality management system certified according to ISO 13485 Quality Management Systems for Medical Device Manufacturer, EU and USA product certifications as well as ISO 14000, 18000 and 27000 (Information Security Management Systems). Visaris has a healthcare market presence on 5 continents and over 20 countries through a network of product distributors. 

Partner’s role: 

Visaris will actively contribute in the design of image processing and analytics pipelines and imaging algorithms. Additionally, Visaris will function as a data provider through curation of lung cancer diagnostic images and other related data as well as development of integration pathways of AI based analysis tools into diagnostic imaging products for clinical practice, as well as their marketing and market visibility. 

Fundació TIC Salut Social is a public agency within the Catalan Ministry of Health founded in 2006 whose aim is to facilitate and promote the development and transformation of health and social care models fostering innovation in the use of ICT.

The main areas of expertise are: Artificial Intelligence, Digital Medical Imaging, Interoperability and Standards, mHealth, Health Data Protection Office and ICT Social Health Hub.

Partner’s role:

Fundació TIC Salut Social leads the Communication, raising awareness and clustering activities of the project and several project tasks, including the Machine Learning-based Explainability.and Standardization actions.

Hellenic Cancer Society is a non-profit Organization, founded in 1958, with the aim of fighting cancer. In this context, it seeks to inform the public on various types of cancer and to promote prevention, through leaflets and booklets, written by specialists on each given subject. What is more, HCS provides training to medical and nursing personnel, and financially supports seminars and congresses that are organized locally. Such actions are of great use to the nursing staff, providing much needed up-to-date information on oncology-related issues. Hellenic Cancer Society became a UICC full member in 1963.

Partner’s role:

HCS will provide the necessary clinical knowledge in order to set up the Pilot by specifying end-users’ requirements and drafting the clinical protocol. Hospital registries including cancer data will be granted from HCS at the beginning of the project to be used for the development of the AI models. HCS will also provide the clinical environment for recruiting, training and monitoring the patients/participants of the trials.

Pagkyprios Syndesmos Karkinopathon and Filon 1986 is a voluntary, non-governmental health association dedicated to fighting cancer through education and awareness and improving the quality of life of cancer patients and their families through health care services offered and advocacy. PASYKAF provides continuing care to patients who require nursing and medical care at any phase of illness while being in the comfort of their homes. For the patients who are in the advanced stage of the disease, care delivery aims to provide comfort by relieving pain and other distressing symptoms – Palliative Care.

PASYKAF participates in the INCISIVE project through its R&D Department established in 2018 specializing, in research funding in health and social matters in projects funded by the EU and international levels. We participate, both as coordinator and partner, in several research projects funded by the EU, such as HORIZON 2020, ERASMUS+ and EEA Grants, the Cyprus Research Promotion Foundation and, other sources.

Partner’s role:

PASYKAF will participate in the user requirements definition task, as well as contribute to the INCISIVE evaluation and dissemination tasks. Its role is to bring patient views and feedback to the project.

University and Policlinico Tor Vergata (PTV) have a team of over 2,000 physicians, biologists and technologist. The Faculty of Medicine of the University of Rome “Tor Vergata” (UNITOV) together with the Policlinico Tor Vergata (PTV) have a team of over 2,000 physicians, biologists and technologists devoted to the study of epidemiological, clinical and experimental aspects of human diseases. The activity in both hospital and university facilities is aimed at developing research, both experimental and clinical, as evidenced by the intense scientific production, especially represented by the number and originality of annually published papers in international journals of high qualification.

Partner’s role

The main objective is to represent personalized care pathways for patients and the various constraints to be considered in identifying and designing improvements including medical, social and economic objectives. Moreover, UNITOV will contribute to providing clinical, diagnostical and imaging experience in cancer cases. UNITOV will function as a data provider and it will participate in the INCISIVE validation study.

The National and Kapodistrian University of Athens (UOA) is a public non-profit Educational institution. The Medical Physics Laboratory and the 2nd Radiology Laboratory are integrated into the UOA Medical School, with active involvement on various academic, research and clinical projects. The School of Medicine operates since 1837 with significant academic recognition. During these years a very important educational, research, clinical and social work has been done. Currently the educational work of the about 600 Professors concerns of over 2.500 undergraduates, 3.000 graduate students and 3.000 doctoral candidates. The recent research work contributes in making our school one of the world’s leading Medical Institutions, preceding the 2/3 of the American Medical Schools.

The Medical Physics Laboratory (MPL) operating under the Basic Medical Sciences Department of the School of Medicine was the first to be established in Greece in 1979. MPL is located in the campus of the UOA School of Medicine and its main goal is to contribute in promoting medical services quality through education and applied research within a university clinical environment surrounded by multi-professional university team members. Τhe MPL closely collaborates with the 2nd Radiology Laboratory which is based in “Attikon” Hospital, the largest University Hospital in Greece. The 2nd Radiology Lab offers clinical and educational services of the highest standards, while pursuing research in all areas of diagnostic and interventional radiology.

Partner’s role:

UOA will participate in the pilot studies based on patient data related to lung and prostate cancer. UOA will be involved in most of the WP’s of the project, providing a series of medical data (demographic, somatometric, imaging, biochemical, histopathological and clinical data), offering clinical expertise and drafting end-users requirements. Patient registries with annotated images, as well as biochemical and clinical information will be provided for developing, testing and assessing the AI models and algorithms developed during the project.

University of Helsinki is the largest institution of academic education in Finland, an international scientific community of 40,000 students and researchers. The UH Faculty of Medicine is highly ranked in several international comparisons (within 50 best faculties). The high-quality medical research conducted there ranges from basic biological research to clinical applications. The operational environment of the Faculty of Medicine is defined by its crucial role as part of the tightly knit research community of the Academic Medical Centre Helsinki (AMCH). AMCH is an internationally renowned medical campus, comprised of the Faculty of Medicine, the Helsinki University Hospital (HUS) and the Institute for Molecular Medicine Finland (FIMM). The hospital has also established the first Nordic OECI-accredited Comprehensive Cancer Center Finland. The University of Helsinki has outstanding precision cancer research reflected by e.g., 16 ERC grants.

Partner’s role:

The research group led by prof. Hautaniemi participating in the project has a strong track-record in developing and applying AI methods to biomedical and clinical data. In INCISIVE, the role of UH is on computational analysis of histopathological images with the aim of predicting patient response to therapy. They will also contribute to processing and integrating clinical data to sequencing and histopathological data.

The Consorci Institut D’Investigacions Biomediques August Pi i Sunyer (IDIBAPS) is a public research centre dedicated to translational research in the field of biomedicine. Its mission is to integrate state of the art basic research and quality clinical research. Founded in 1996, IDIBAPS is formed by the Government of Catalonia (Generalitat de Catalunya), the Hospital Clínic de Barcelona Consortium and the Universitat de Barcelona. The institution is very active in scientific research (e.g. 1,282 indexed original articles in 2018). The facts and figures of IDIBAPS guarantee its excellence (e.g. mean impact factor of 6.51 in 2018). Moreover, IDIBAPS ranks first in scientific productivity and quality among the Certified Health Research Institutes of Spain. Likewise, IDIBAPS has a strong track record working in European projects and has a dedicated European Projects Office (OPE) and the Knowledge and Technology Transfer Office (KTT). The OPE managed 34 projects in FP5 (1 as coordinators), 55 projects in FP6 (11 as coordinators), 130 projects in FP7 (29 as coordinators) and is currently managing over sixty projects in H2020 (10 as coordinators).

IDIBAPS is provided with all the necessary laboratories, equipment and scientific support required for its researchers. Besides, IDIBAPS disposes of a large unit of project managers that are in charge of assisting the researchers with international projects issues. Moreover, full secretarial, management and financial support will be available for the researcher.

Hospital Clinic de Barcelona (HCB) is a linked third party of IDIBAPS with a legal link to the beneficiary implying collaboration that is not limited to the action and it is reflected on the statutes of the beneficiary. The HCB is a university tertiary hospital located in Barcelona. It is a public institution with a long reputation of excellence in care provision, training and research at national and international level. HCB is a community hospital that employs around 4.000 workers (23% doctors, 55% nurses and 22% clerical and other supportive staff). As a Tertiary Hi-tech Hospital, the goals are around consolidating an organisation that stimulates knowledge and its translation to mainstream services, together with an adequate innovation in technology that ensures the development of the most advanced work practices. The priority is set in innovation on new models of organising care provision. HCB has pursued the creation of an integrated care model of service integration aiming at maximising cooperation among professionals, levels of care and institutions.

Partner’s role:

IDIBAPS will participate in the project by providing clinical experience in the cancer cases in order to define user cases developed in this project. In addition, we will participate in validation studies. The partner will provide clinical and radiological data related to prostate cancer patients to develop AI model in the different assigned workshops.

The Linac-Pet Scan Opco Ltd (Legal name) belongs to the broader group of the German Oncology Center (Business name), which provide their services in general as an oncology center. GOC is a newly established Oncology Centre, founded by a world-renowned group of oncologists with significant prior experience at oncology centers and clinics in Germany and with core expertise in radiation oncology and innovative radiotherapy. The group has a strong record in both basic and clinical research, focusing on the translation of research results into innovative diagnostic and therapeutic services relating to all aspects of medical oncology.

Partner’s role:

GOC will function as data provider of digital images derived from computed tomography (CT), magnetic resonance imaging (MRI), radiographic tests (e.g. X-rays), nuclear medicine scans (e.g. PET) and ultrasound (US) examinations, as well as it will participate in the INCISIVE validation studies and the definition of the user requirements.

Kingston University is an innovative modern research led University which has four campuses and five faculties. The largest of these Faculties is the Faculty of Science, Engineering and Computing (SEC).

SEC is strategically focused on inter-disciplinary research and researchers in SEC collaborate widely, within the Faculty, across Faculties as well as with a wide range of national and international partners, academic and industrial.

The KU team belong to the school of Pharmacy and have significant experience in designing and conducting in depth needs assessment and evaluation strategies for digital interventions using a mix of quantitative and qualitative research methods.

Partner’s role:

Kingston University will be responsible for the user requirements definition. In addition, KU will be leading WP6, actively contributing to the execution of the pilot studies at the clinical sites and evaluation of their results. Kingston University will also support the clinical partners with all the required ethical approval actions, in collaboration with Timelex.

Cyprus University of Technology (CUT) has as its strategic target the design and development of research activities both within the University and in cooperation with other research Institutes in Cyprus and abroad. The research emphasis of CUT is reflected in the substantial funding provided to academics for the establishment of research centres and laboratories. CUT aims at transferring knowledge (education) and producing new knowledge through basic and applied research in all the academic fields of the University’s five Faculties.

The Cyprus University of Technology participates in the INCISIVE project through it’s Nursing Department. The Department of Nursing is a dynamic and driven community of scholars and clinicians with a common goal: to pursue academic excellence of practical value in nursing and healthcare services. As the largest nursing faculty in the country is the only one to offer a full range of undergraduate and graduate degree programs. The staff members are making significant contributions to the needs of the local community and dedicating their knowledge and expertise in facilitating the development of nursing scholarship nationally and internationally. With an extensive international network of collaborative research partners, the Department has attracted significant internal and external funds to produce high-quality projects (both as coordinator and partner) with a National but most importantly International impact on a wide portfolio of health-related issues. These include the influence of disease (i.e. cancer) or treatment-induced side-effects on patients’ well-being, Quality of Life (QoL) and functional status, the use of ICT programs to support the self-management of care of patients living at home, the use of non-pharmacological interventions to manage treatment-induced toxicities of targeted therapies to report a few.

Partner’s role:

The CUT will lead INCISIVE pilots protocol definition, which includes the design and development of a study protocol that provides the framework for organising and standardising the multi-site clinical study that will be undertaken as part of the project.

Timelex is a leading niche law firm based in Brussels specialised in the legal aspects of information technology (IT), privacy & data protection (GDPR), intellectual property, and media & electronic communications. Timelex’s private-sector clients are multinationals, large companies, SMEs and start-ups. Their public-sector clients include European, federal, regional, local and foreign governments and governmental bodies. Timelex frequently assists companies in establishing suitable policies and legal frameworks in their data management activities, including with regard to the cross-border transfer and processing of personal data, data security and liability management issues. The Timelex team is specifically known for its European policy studies in a variety of subjects, including data protection, electronic signatures, electronic identity management, e-business and e-government, in which they can rely on an extensive network of IT law experts covering all European countries.

Partner’s role:

Timelex acts as a lawyer to the consortium, dealing with all legal aspects as they arise and providing support to consortium partners where needed. Specifically, Timelex will take care of the data protection questions in INCISIVE and the related ethical aspects (together with Kingston University).

White research is a social research consulting firm, specializing in innovation management, consumer behaviour, market analysis and business modelling and planning in the fields of Health, Transport, Energy, Agriculture, Smart Cities, ICT and other related sectors and sub-fields. It mines and interprets hard-to-grasp consumer and user insights through a combination of modern analytics, marketing research, collective intelligence and evaluation methods to design efficient actions that put the end-user at the centre of the decision-making process. In line with the above, White Research possesses valuable know-how and expertise in offering business support and innovation management services in relation to business modelling and planning, market analysis and risk analysis, and supports the commercial exploitation and market uptake of research results and innovations. WR has acted as an Innovation Manager in in-going and past Horizon 2020 projects, paving the way for the market uptake and adoption of project assets.

Partner’s role:

White Research is the INCISIVE Project Leader of Innovation Management, Exploitation and Sustainability Planning. As such the company will be responsible for the analysis of the market targeted by INCISIVE, the definition of suitable and sustainable business models, their validation and improvement and finally, for the elaboration of the INCISIVE Business Plan. White Research is also responsible for the definition of the Innovation strategy of the project. Additionally, White Research has an active role in awareness-raising, communication and dissemination, providing meaningful support to the respective marketing campaign of the INCISIVE project.

Medtronic is a worldwide leading Healthcare Technology Innovation Company whose mission is alleviating pain, restoring health and extending life. Medtronic is one of the most meaningful actors in the provision of innovative solutions, given its widespread reach, know-how and market traction.

Since 2012 Medtronic has incorporated a new business unit called “Integrated Health Solutions” focused on developing solutions, products and services, that bring operational excellence into different hospital units. Medtronic has evolved to be a Health solutions and services company with the application of the Value-Based Healthcare principles in real clinical settings, keeping the patient at the centre of the care delivery process.

The “Innovation and Projects department” of Medtronic Ibérica inside Integrated Health Solutions has high experience in coordination and participation in collaborative projects in the national and European framework, Medtronic Ibérica has participated in several European Projects since 2004.

Partner’s role:

Medtronic, as a key industrial partner, will take an active part in the elaboration of the Business Model and the exploitation plans of the results achieved during the project, the deployment of the INCISIVE solution and the analysis of its fit in the healthcare systems. In addition, Medtronic will hold the role of Repository Coordinator, with the main objective of creating and enlarging the ecosystem orbiting around the platform developed, promoting its visibility and widespread acknowledgement.